Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, Wegovy side effects appear within the first one to three days of each new dose — with nausea being the most commonly reported, often peaking in the 24 to 48 hours after an injection. That pattern is consistent across the STEP trial programme and is reflected in the NHS's clinical guidance on semaglutide. These medicines are prescription-only, and the timing and severity of any side effects can vary considerably from person to person, which is why clinical assessment before starting matters.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial (which followed over 1,900 adults on semaglutide 2.4mg across 68 weeks) found that gastrointestinal side effects were most common during the dose-escalation phase, not at maintenance. That means the weeks when your dose is stepping up are the ones most likely to feel unsettled. The findings are published in the New England Journal of Medicine and have since shaped how prescribers counsel patients before they start.
In practical terms, nausea typically arrives within a day of the injection and, for most people, fades within two to four days. It does not usually last the full week between doses. Diarrhoea and constipation tend to follow a similar pattern, though they can be less predictable. Fatigue and mild headache are also reported more often in the early weeks. If you want a closer look at exactly when nausea tends to begin after a Wegovy injection, that question is covered in more detail separately.
One thing worth knowing: the first dose at 0.25mg is a tolerability dose. Its job is to let your system adjust before the dose increases. Side effects at this level are generally mild, and some people notice very little at all. The more noticeable reactions tend to coincide with each subsequent step up.
There is a meaningful difference between what happens during escalation and what you might experience once you have been on a stable dose for several months. If you are curious about how soon side effects from Wegovy tend to appear, the NHS guidance on semaglutide notes that side effects are most pronounced early in treatment and at each dose change, a pattern that aligns with how the medicine interacts with gut-hormone receptors and gastric emptying.
Once your dose has been stable for four to six weeks, many people find the side-effect profile quietens considerably. That is not universal (some individuals continue to notice mild nausea for longer) but it is the common trajectory. The full range of Wegovy's reported side effects includes burping, reflux, and injection-site reactions alongside the more familiar GI symptoms, and timing varies across all of them.
If you are considering Wegovy or have recently started, understanding this escalation dynamic helps set realistic expectations. Stopping treatment because of early nausea that would have settled within a week is one of the most common reasons people do not see results, a point our prescribers at nume discuss with patients as part of the initial consultation.
Most side effects from Wegovy are unpleasant rather than dangerous, and the appropriate response is usually hydration, smaller meals, and time. Some symptoms, though, should not be waited out.
In January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known but infrequent risk with GLP-1 medicines. The signal to act quickly is severe stomach pain that does not pass and may spread towards the back, sometimes with vomiting. That pattern warrants same-day medical contact, not a call to your pharmacy. The MHRA's Drug Safety Updates are publicly available and worth bookmarking.
Other symptoms that need prompt attention include: signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, rapid heartbeat), severe or persistent vomiting that stops you keeping fluids down, or symptoms of dehydration such as dark urine and dizziness that does not settle. If you are unsure whether what you are experiencing falls into the category that needs urgent review, the honest answer is to seek help rather than wait. You can also report any suspected side effect to the MHRA via the Yellow Card scheme, which helps build the national safety picture for these medicines.
Keeping your pen stored correctly is part of avoiding unnecessary problems, Wegovy should be refrigerated between 2°C and 8°C (the MHRA-approved SmPC has the exact room-temperature window if you need it for travel). Many people find it easiest to keep the pen in the fridge door, somewhere visible, so it becomes part of the routine rather than an afterthought.
Beyond storage, the evidence from the STEP programme points to a few practical patterns that help with tolerance: smaller portions at each meal, eating slowly, avoiding fatty foods in the days around your injection, and staying well hydrated. People often ask how soon after taking Wegovy they should expect to feel any effects, and understanding that window can make it much easier to plan meals and activity around your injection day. A broader overview of how Wegovy works and what treatment involves covers the lifestyle context in more detail.
If side effects are weighing on your decision about whether to start, it is also worth reading about how soon most people actually feel Wegovy's side effects, since knowing what is typical can make the early weeks feel far less daunting. Check your eligibility and start a free consultation, it costs nothing, takes place the same day, and a real clinician reviews your answers before anything is prescribed.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.